.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Colorcon
Chinese Patent Office
US Army
UBS
Deloitte
Farmers Insurance
Argus Health
Dow
McKesson

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076788

« Back to Dashboard

NDA 076788 describes MOMETASONE FUROATE, which is a drug marketed by Fougera Pharms, G And W Labs, Glenmark Generics, Taro, Tolmar, Perrigo Israel, Perrigo New York, Amneal Pharms, and Apotex Inc, and is included in nineteen NDAs. It is available from eighteen suppliers. Additional details are available on the MOMETASONE FUROATE profile page.

The generic ingredient in MOMETASONE FUROATE is mometasone furoate. There are twenty-nine drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.

Summary for 076788

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 076788

Medical Subject Heading (MeSH) Categories for 076788

Suppliers and Packaging for NDA: 076788

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MOMETASONE FUROATE mometasone furoate LOTION;TOPICAL 076788 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1305 51672-1305-4 1 BOTTLE in 1 CARTON (51672-1305-4) > 60 mL in 1 BOTTLE
MOMETASONE FUROATE mometasone furoate LOTION;TOPICAL 076788 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1305 51672-1305-3 1 BOTTLE in 1 CARTON (51672-1305-3) > 30 mL in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrength0.1%
Approval Date:Mar 15, 2006TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
QuintilesIMS
Chubb
Merck
Queensland Health
Mallinckrodt
Covington
Argus Health
Novartis
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot